Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Frontiers in Pharmacology
|
October 30, 2023
Reimbursement decision-making system in Poland systematically compared to other countries
Aneta Mela, Elżbieta Rdzanek, Janusz Jaroszyński, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 9, 2018
The direct and indirect costs of epilepsy in Poland estimates for 2014-2016 years
Aneta Mela, Anna Staniszewska, Witold Wrona, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
January 23, 2024
AOTMiT reimbursement recommendations compared to other HTA agencies
Aneta Mela, Dorota Lis, Elżbieta Rdzanek, et al.
Annals of Agricultural and Environmental Medicine : AAEM
|
December 28, 2020
Prevalence and selected determinants of the risk of problem gambling among Polish secondary school students
Iwona Niewiadomska, Lech Panasiuk, Joanna Chwaszcz, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 21, 2024
Time from approval to reimbursement recommendations in healthcare systems with centralized HTA processes. Focus on the Polish HTA agency
Aneta Mela, Andrzej Tysarowski, Elżbieta Rdzanek, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
November 28, 2022
The impact of changing the funding model for genetic diagnostics and improved access to personalized medicine in oncology
Aneta Mela, Elżbieta Rdzanek, Andrzej Tysarowski, et al.
Frontiers in Pharmacology
|
October 5, 2020
Economic Costs of Cardiovascular Diseases in Poland Estimates for 2015-2017 Years
Aneta Mela, Elżbieta Rdzanek, Łukasz A Poniatowski, et al.
Medycyna Pracy
|
May 22, 2019
[Cytostatic and cytotoxic waste - rules of conduct in Poland]
Marzena Furtak-Niczyporuk, Janusz Jaroszyński, Aneta Mela, et al.
Neural Plasticity
|
April 3, 2019
Brain Functional Reserve in the Context of Neuroplasticity after Stroke
Jan Dąbrowski, Anna Czajka, Justyna Zielińska-Turek, et al.
Frontiers in Pharmacology
|
September 14, 2020
Overview and Analysis of the Cost of Drug Programs in Poland: Public Payer Expenditures and Coverage of Cancer and Non-Neoplastic Diseases Related Drug Therapies from 2015-2018 Years
Aneta Mela, Łukasz A Poniatowski, Bartłomiej Drop, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Frontiers in Pharmacology
|
October 30, 2023
Reimbursement decision-making system in Poland systematically compared to other countries
Aneta Mela, Elżbieta Rdzanek, Janusz Jaroszyński, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 9, 2018
The direct and indirect costs of epilepsy in Poland estimates for 2014-2016 years
Aneta Mela, Anna Staniszewska, Witold Wrona, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
January 23, 2024
AOTMiT reimbursement recommendations compared to other HTA agencies
Aneta Mela, Dorota Lis, Elżbieta Rdzanek, et al.
Annals of Agricultural and Environmental Medicine : AAEM
|
December 28, 2020
Prevalence and selected determinants of the risk of problem gambling among Polish secondary school students
Iwona Niewiadomska, Lech Panasiuk, Joanna Chwaszcz, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 21, 2024
Time from approval to reimbursement recommendations in healthcare systems with centralized HTA processes. Focus on the Polish HTA agency
Aneta Mela, Andrzej Tysarowski, Elżbieta Rdzanek, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
November 28, 2022
The impact of changing the funding model for genetic diagnostics and improved access to personalized medicine in oncology
Aneta Mela, Elżbieta Rdzanek, Andrzej Tysarowski, et al.
Frontiers in Pharmacology
|
October 5, 2020
Economic Costs of Cardiovascular Diseases in Poland Estimates for 2015-2017 Years
Aneta Mela, Elżbieta Rdzanek, Łukasz A Poniatowski, et al.
Medycyna Pracy
|
May 22, 2019
[Cytostatic and cytotoxic waste - rules of conduct in Poland]
Marzena Furtak-Niczyporuk, Janusz Jaroszyński, Aneta Mela, et al.
Neural Plasticity
|
April 3, 2019
Brain Functional Reserve in the Context of Neuroplasticity after Stroke
Jan Dąbrowski, Anna Czajka, Justyna Zielińska-Turek, et al.
Frontiers in Pharmacology
|
September 14, 2020
Overview and Analysis of the Cost of Drug Programs in Poland: Public Payer Expenditures and Coverage of Cancer and Non-Neoplastic Diseases Related Drug Therapies from 2015-2018 Years
Aneta Mela, Łukasz A Poniatowski, Bartłomiej Drop, et al.
Page
of 2